Trademark: REBLOZYL 1843749
Word
REBLOZYL
ID
1843749
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
14 February 2017
Registration Date
14 February 2017
Renewal Date
14 February 2027
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system